Hyperion Defi

HYPDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.926 M

$2.70 +1.12%

Close of 7 Aug 2026

Revenue

$813.5K

#3517 by revenue

Earnings

-$45.3M

Loss-making

Shares outstanding

11,391,645

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#358Context TherapeuticsCNTX$44.5M
#359PDS BiotechnologyPDSB$43.4M
#360Hyperion DefiHYPD$40.9M
#361Nasus PharmaNSRX$40.5M
#362Radiopharm TheranosticsRADX$40.3M

Where these numbers come from

Share counts and financials for Hyperion Defi are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.